There is no commercial support for this activity.

About the speaker

Dr. Tariot is Board Certified in Internal Medicine and Psychiatry with added qualifications in geriatrics.  He was a Fellow at the National Institute of Mental Health (NIMH) Intramural Research Program, then served as a faculty member at the University of Rochester Medical Center and, since 2006, he has served as Director of the Banner Alzheimer’s Institute in Phoenix. He is also a Research Professor of Psychiatry at the University of Arizona College of Medicine. His work has focused on care and study of people with and at risk for Alzheimer’s, with special emphasis on design and implementation of clinical trials for prevention and treatment, development of biomarkers, measurement, and treatment of neuropsychiatric features of dementia and demonstration of effective dementia care. His experience includes conceiving, funding, and implementing single center and multicenter trials, and serving as Principal Investigator on over 50 clinical trials related to Alzheimer’s and related dementias. He has published over 400 papers on these topics including those regarding studies that have led to FDA approval of new medications. He serves as co-director of the international Alzheimer’s Prevention Initiative (API). His research affiliations include the National Institute on Aging (NIA), the NIMH, and the Alzheimer’s Association and he is a Fellow of the American College of Neuropsychopharmacology.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Pierre N. Tariot, MD, reports having the following relationships with commercial interests: Abbvie-Consultant-Honoraria; AC Immune-Consultant-Honoraria; Acadia-Consultant-Honoraria; Clinical Care Options-Consultant-Honoraria; CME Outfitters-Speaker-Honoraria; Cortexyme-Consultant-Honoraria; Eisai-Consultant-Honoraria, MedEdicus-Speaker-Honoraria; Merck-Consultant. He will be discussing experimental treatments for Alzheimer’s. All relationships have been mitigated. This presentation will focus on research. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, Lisa Illum MLIS, MEd,  and Jennifer Tornabene.